Top Markets
Coin of the day
Orexo AB Orexo AB

Orexo AB

ORX
Peringkat dalam Saham #24889
Orexo AB (publ), a specialty pharmaceutical company, develops and... Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, the United Kingdom, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of insomnia. The company is developing OX124 for opioid overdose; OX125 for rescue medication and opioid overdose; OX640 to treat anaphylaxis with powder-based epinephrine; and OX-MPI for the treatment of endometriosis. Its digital therapies include deprexis for the treatment of depression; vorvida for alcohol management; and modia for opioid use disorder. The company has a collaboration agreement with Abera Bioscience AB to develop nasal powder vaccines based on the AmorphOX technology. Orexo AB (publ) was founded in 1994 and is headquartered in Uppsala, Sweden.
Harga Saham
$1.58
Kapitalisasi Pasar
$55.48M
Perubahan (1 hari)
0.86%
Perubahan (1 tahun)
-28.33%
Negara
SE
Perdagangan Orexo AB (ORX)

Kategori

Riwayat harga saham Orexo AB (ORX)
Harga penutupan tertinggi: $1.66 pada 2026-08-01

Harga penutupan terendah: $10.87 pada 2005-11-01
Riwayat harga saham Orexo AB dari 2005 hingga 2026
Performa harga saham tahunan
Tahun Performa
2026 (TTM) -0.36%
2025 71.17%
2024 1.53%
2023 -16.60%
2022 -53.35%
2021 -27.52%
2020 -16.22%
2019 -4.07%
2018 41.00%
2017 22.89%
2016 -47.52%
2015 -55.53%
2014 -33.94%
2013 226.23%
2012 110.17%
2011 -35.82%
2010 15.15%
2009 9.60%
2008 -38.49%
2007 -59.09%
2006 46.28%
2005 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
$60.43 66.43%
US
$51.27 72.45%
SE
$192.16 42.27%
FR
$119.82 68.80%
US
$0.72 -27.55%
HK